Group One Trading
TARA icon

Group One Trading’s Protara Therapeutics TARA Stock Holding History

Group One Trading’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Hold
4,000
– – ﹤0.01% 6169
2026
Q1 		$20.8K Sell
4,000
-2,500
-38% -$14.8K ﹤0.01% 5943
2025
Q4 		$34.6K Sell
6,500
-1,000
-13% -$5.56K ﹤0.01% 5897
2025
Q3 		$32.6K Buy
7,500
+7,000
+1,400% +$22.7K ﹤0.01% 6300
2025
Q2 		$1.51K Buy
+500
New +$1.73K ﹤0.01% 7484
2025
Q1 		– Sell
-34,100
Closed -$180K – 8358
2024
Q4 		$180K Buy
+34,100
New +$110K ﹤0.01% 4021
2024
Q3 		– Sell
-1,900
Closed -$3.95K – 7352
2024
Q2 		$3.95K Buy
+1,900
New +$5.55K ﹤0.01% 6047
2022
Q2 		– Sell
-1,200
Closed -$6K – 8509
2022
Q1 		$6K Sell
1,200
-300
-20% -$1.58K ﹤0.01% 7402
2021
Q4 		$10K Buy
1,500
+1,100
+275% +$7.58K ﹤0.01% 7358
2021
Q3 		$3K Buy
+400
New +$3.12K ﹤0.01% 7889

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Group One Trading's TARA Position: Q2 2026 in Review

Group One Trading reduced its Protara Therapeutics (TARA) stake by 99% in Q2 2026, selling an estimated $6.1K and leaving 14 shares worth $53. The position accounts for ﹤0.01% of the portfolio, ranked #7431.

Group One Trading first reported a position in TARA in Q2 2024 and has held it in 6 quarters since. The position peaked at $98.1K in Q4 2025. 119 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Group One Trading held 14 shares of Protara Therapeutics worth $53 as of Q2 2026.
  • Group One Trading sold 1,283 Protara Therapeutics shares in Q2 2026, an estimated $6.1K.
  • Protara Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7431 holding.
  • Group One Trading first reported a position in Protara Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • Group One Trading's Protara Therapeutics position peaked at $98.1K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.